Drugs in snowflake shapes

The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap

This Review in the January issue discusses the concept of N-of-1 therapies and illustrates advances and challenges in the field using cases for which therapies have been successfully developed.  

  • Anneliene H. Jonker
  • Elena-Alexandra Tataru
  • Annemieke Aartsma-Rus
Review Article

Announcements

Advertisement

    • Impaired mitophagy leading to the accumulation of damaged mitochondria is associated with the onset and progression of neurodegenerative diseases. This Review provides an overview of the molecular pathways of mitophagy regulation in neurons, discusses evidence implicating mitophagy impairment in the pathogenesis of neurodegenerative diseases and assesses small-molecule-based therapeutic approaches aimed at selective mitophagy enhancement.

      • Odetta Antico
      • Paul W. Thompson
      • Laura E. Parton
      Review Article
    • Recent advances in structural biology techniques and computational simulations have enhanced our understanding of the conformational dynamics of G protein-coupled receptors and their interactions with ligands. This Review highlights how such advances may be used in the discovery and optimization of drugs that target G protein-coupled receptors, focusing on three categories: allosteric modulators, biased ligands, and bivalent and bitopic compounds.

      • Paolo Conflitti
      • Edward Lyman
      • Vittorio Limongelli
      Review Article
    • CRISPR technology is revolutionizing the development of therapies for genetic disorders. However, the application of CRISPR-based therapeutics is challenged by factors impacting stability, efficiency, delivery and safety. This Review focuses on chemical engineering of CRISPR–Cas systems to address these issues, it assesses next-generation CRISPR–Cas systems, and it highlights CRISPR-based therapies that are approved or in clinical development.

      • Halle M. Barber
      • Adrian A. Pater
      • Daniel O’Reilly
      Review Article
    • Regulatory T cells keep the immune system in check to maintain homeostasis and restrain inflammation. This Review discusses strategies to harness these cells therapeutically for autoimmunity, transplant tolerance or cancer, for example, by boosting their endogenous function, depleting them or administering them as engineered cell-based therapies.

      • Christine M. Wardell
      • Dominic A. Boardman
      • Megan K. Levings
      Review Article
    • CD8 T cells and natural killer (NK) cells play a key role in cancer immunosurveillance. However, their anticancer activity is rapidly diminished in the tumour microenvironment, associated with a decline in their metabolic function. This Review provides an overview of metabolic programmes in CD8 T cells and NK cells, discusses the dysfunction that can occur in cancer, and assesses therapeutic strategies to overcome this.

      • Sébastien Viel
      • Eric Vivier
      • Antoine Marçais
      Review Article
lona Nagy/Getty

Navigating the vaccines landscape

We explore the latest developments in the vaccines field, through our editorial feature and showcase of companies.
Collection

Advertisement

Nature Careers

Science jobs

Advertisement